Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.

Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI; Tumour and Angiogenesis Research Group.

Cancer. 2001 Nov 15;92(10):2569-77.

PMID:
11745191
2.

Angiogenesis and endometrial cancer.

Sivridis E.

Anticancer Res. 2001 Nov-Dec;21(6B):4383-8. Review.

PMID:
11908694
3.

[Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].

Sato K, Kato T.

Gan To Kagaku Ryoho. 1997 Feb;24(4):389-94. Review. Japanese.

PMID:
9063473
4.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
5.

Prognostic value of vascular endothelial growth factor in breast cancer.

Gasparini G.

Oncologist. 2000;5 Suppl 1:37-44. Review.

7.

The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.

Arastéh K, Hannah A.

Oncologist. 2000;5 Suppl 1:28-31. Review.

8.

VEGF receptor signaling in tumor angiogenesis.

McMahon G.

Oncologist. 2000;5 Suppl 1:3-10. Review.

9.

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.

Brekken RA, Thorpe PE.

J Control Release. 2001 Jul 6;74(1-3):173-81. Review.

PMID:
11489493
10.

Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.

Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S.

Med Sci Monit. 2000 Sep-Oct;6(5):1047-52. Review.

PMID:
11208453
12.
13.

Structure and function of VEGF/VEGF-receptor system involved in angiogenesis.

Shibuya M.

Cell Struct Funct. 2001 Feb;26(1):25-35. Review.

14.

VEGF receptor signal transduction.

Matsumoto T, Claesson-Welsh L.

Sci STKE. 2001 Dec 11;2001(112):re21. Review.

PMID:
11741095
15.

Anti-angiogenic gene therapy of malignant glioma.

Stratmann A, Machein MR, Plate KH.

Acta Neurochir Suppl. 1997;68:105-10. Review.

PMID:
9233424
16.

Gene regulation and arteriosclerosis: are developmental programs reactivated in vascular disease?

Patterson C.

Thromb Haemost. 1999 Sep;82 Suppl 1:27-31. Review.

PMID:
10695482
17.

VEGF antagonists.

Hasan J, Jayson GC.

Expert Opin Biol Ther. 2001 Jul;1(4):703-18. Review.

PMID:
11727506
18.

Regulation of VEGF in the reproductive tract by sex-steroid hormones.

Hyder SM, Stancel GM.

Histol Histopathol. 2000 Jan;15(1):325-34. Review.

PMID:
10668221
19.

The diagnostic and prognostic value of tumor angiogenesis.

Szabo S, Sandor Z.

Eur J Surg Suppl. 1998;(582):99-103. Review.

PMID:
10029373
20.

Angiogenesis in malignancies of the female genital tract.

Abulafia O, Triest WE, Sherer DM.

Gynecol Oncol. 1999 Feb;72(2):220-31. Review.

PMID:
10021305

Supplemental Content

Support Center